We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 Jan - 31 Mar 2024.
The characteristics, diagnosis, management, surveillance and epidemiology of Klebsiella species.
Launched in January 2024, IRP aims to further help bring life-saving new medicines to UK patients without delay
Batches of some products made by Legency Remedies Pvt Ltd have been found to contain a bacteria called Ralstonia pickettii (R. pickettii). All potentially affected batches are being recalled following an MHRA investigation.
From 1 July 2016, the number of doses of the Meningococcal C (MenC) vaccine in the infant schedule are being reduced.
Advice and guidance on the health needs of migrant patients for healthcare practitioners
The What Works Network uses evidence to improve the design and delivery of public services.
How to use feedback from marketplace reviews to evaluate your digital health product.
Explains changes to drug driving law and the guidance available for healthcare professionals and users of prescription medicine.
Do not stop your hypertriglyceridemia treatment without a discussion with your doctor
The CMA is investigating the acquisition by Theramex HQ UK Limited of the certain rights to Viatris Inc’s Femoston and Duphaston products.
Collection of information and guidance for patients and for healthcare professionals on the reproductive risks of valproate and new safety measures introduced to reduce these risks.
Applications received to amend the specification of a patent under sections 27 and 75 before the court and the Office.
Sets out legal text on the manufacture, authorisation, marketing, distribution and post-authorisation surveillance of veterinary medicines.
Form FGM003: Application to vary, extend or discharge a Female Genital Mutilation (FGM) Protection Order.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
An accelerated licensing process may apply to some applications for dredging activity.
Imposing safeguard measures for imports of certain steel products.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.